PURPOSE: The outcome of surgery in patients with temporal lobe epilepsy (TLE) and normal high-resolution magnetic resonance imaging (MRI) has been significantly worse than in patients with unilateral hippocampal damage upon MRI. The purpose of this study was to determine the long-term outcomes of consecutive true MRI-negative TLE patients who all underwent standardized preoperative evaluation with intracranial electroencephalography (EEG) electrodes. METHODS: In this study we present all adult MRI-negative TLE surgery candidates evaluated between January 1990 and December 2006 at Kuopio Epilepsy Center in Kuopio University Hospital, which provides a national center for epilepsy surgery in Finland. During this period altogether 146 TLE surgery candidates were evaluated with intracranial electrodes, of whom 64 patients with normal high-resolution MRI were included in this study. RESULTS: Among the 38 patients who finally underwent surgery, at the latest follow-up (mean 5.8 years), 15 (40%) were free of disabling seizures (Engel class I) and 6 (16%) were seizure-free (Engel class IA). Twenty-one (55%) of 38 patients had poor outcomes (Engel class III-IV). Outcomes did not change compared to 12-month follow-up. Histopathologic examination failed to reveal any focal pathology in 68% of our MR-negative cases. Only patients with noncongruent positron emission tomography (PET) results had worse outcomes (p = 0.044). DISCUSSION: Our results suggest that epilepsy surgery outcomes in MRI-negative TLE patients are comparable with extratemporal epilepsy surgery in general. Seizure outcomes in the long-term also remain stable. Modern imaging techniques could further improve the postsurgical seizure-free rate. However, these patients usually require chronic intracranial EEG evaluation to define epileptogenic areas. Wiley Periodicals, Inc.
PURPOSE: The outcome of surgery in patients with temporal lobe epilepsy (TLE) and normal high-resolution magnetic resonance imaging (MRI) has been significantly worse than in patients with unilateral hippocampal damage upon MRI. The purpose of this study was to determine the long-term outcomes of consecutive true MRI-negative TLEpatients who all underwent standardized preoperative evaluation with intracranial electroencephalography (EEG) electrodes. METHODS: In this study we present all adult MRI-negative TLE surgery candidates evaluated between January 1990 and December 2006 at Kuopio Epilepsy Center in Kuopio University Hospital, which provides a national center for epilepsy surgery in Finland. During this period altogether 146 TLE surgery candidates were evaluated with intracranial electrodes, of whom 64 patients with normal high-resolution MRI were included in this study. RESULTS: Among the 38 patients who finally underwent surgery, at the latest follow-up (mean 5.8 years), 15 (40%) were free of disabling seizures (Engel class I) and 6 (16%) were seizure-free (Engel class IA). Twenty-one (55%) of 38 patients had poor outcomes (Engel class III-IV). Outcomes did not change compared to 12-month follow-up. Histopathologic examination failed to reveal any focal pathology in 68% of our MR-negative cases. Only patients with noncongruent positron emission tomography (PET) results had worse outcomes (p = 0.044). DISCUSSION: Our results suggest that epilepsy surgery outcomes in MRI-negative TLEpatients are comparable with extratemporal epilepsy surgery in general. Seizure outcomes in the long-term also remain stable. Modern imaging techniques could further improve the postsurgical seizure-free rate. However, these patients usually require chronic intracranial EEG evaluation to define epileptogenic areas. Wiley Periodicals, Inc.
Authors: Grand Joldes; George Bourantas; Benjamin Zwick; Habib Chowdhury; Adam Wittek; Sudip Agrawal; Konstantinos Mountris; Damon Hyde; Simon K Warfield; Karol Miller Journal: Med Image Anal Date: 2019-06-12 Impact factor: 8.545
Authors: Jerome Engel; Michael P McDermott; Samuel Wiebe; John T Langfitt; John M Stern; Sandra Dewar; Michael R Sperling; Irenita Gardiner; Giuseppe Erba; Itzhak Fried; Margaret Jacobs; Harry V Vinters; Scott Mintzer; Karl Kieburtz Journal: JAMA Date: 2012-03-07 Impact factor: 56.272
Authors: David B Burkholder; Vlastimil Sulc; E Matthew Hoffman; Gregory D Cascino; Jeffrey W Britton; Elson L So; W Richard Marsh; Fredric B Meyer; Jamie J Van Gompel; Caterina Giannini; C Thomas Wass; Robert E Watson; Gregory A Worrell Journal: JAMA Neurol Date: 2014-06 Impact factor: 18.302
Authors: William H Theodore; Ashley R Martinez; Omar I Khan; Clarissa J Liew; Sungyoung Auh; Irene M Dustin; John Heiss; Susumu Sato Journal: J Nucl Med Date: 2012-07-10 Impact factor: 10.057